Nothing Special   »   [go: up one dir, main page]

SE9403905D0 - New formulations - Google Patents

New formulations

Info

Publication number
SE9403905D0
SE9403905D0 SE9403905A SE9403905A SE9403905D0 SE 9403905 D0 SE9403905 D0 SE 9403905D0 SE 9403905 A SE9403905 A SE 9403905A SE 9403905 A SE9403905 A SE 9403905A SE 9403905 D0 SE9403905 D0 SE 9403905D0
Authority
SE
Sweden
Prior art keywords
new formulations
chitosan polymer
active agent
therapeutic active
formulation
Prior art date
Application number
SE9403905A
Other languages
English (en)
Inventor
Per Artursson
N G M Schipper
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9403905A priority Critical patent/SE9403905D0/sv
Publication of SE9403905D0 publication Critical patent/SE9403905D0/sv
Priority to PCT/SE1995/001342 priority patent/WO1996020730A1/en
Priority to EP95937278A priority patent/EP0792330A1/en
Priority to CA 2203632 priority patent/CA2203632A1/en
Priority to JP8517163A priority patent/JPH10509207A/ja
Priority to AU39433/95A priority patent/AU710769B2/en
Priority to IS4469A priority patent/IS4469A/is
Priority to NO972172A priority patent/NO972172L/no
Priority to FI972056A priority patent/FI972056A0/sv

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9403905A 1994-11-14 1994-11-14 New formulations SE9403905D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9403905A SE9403905D0 (sv) 1994-11-14 1994-11-14 New formulations
PCT/SE1995/001342 WO1996020730A1 (en) 1994-11-14 1995-11-13 A chitosan polymer having a specific degree of acetylation
EP95937278A EP0792330A1 (en) 1994-11-14 1995-11-13 A chitosan polymer having a specific degree of acetylation
CA 2203632 CA2203632A1 (en) 1994-11-14 1995-11-13 A chitosan polymer having a specific degree of acetylation
JP8517163A JPH10509207A (ja) 1994-11-14 1995-11-13 特定のアセチル化度を有するキトサンポリマー
AU39433/95A AU710769B2 (en) 1994-11-14 1995-11-13 A chitosan polymer having a specific degree of acetylation
IS4469A IS4469A (is) 1994-11-14 1997-04-22 Sítósanfjölliða með ákveðið asetýleringar-hlutfall
NO972172A NO972172L (no) 1994-11-14 1997-05-12 Kitosanpolymer med en spesifikk acetyleringsgrad
FI972056A FI972056A0 (sv) 1994-11-14 1997-05-14 Kitosanpolymer med en specifik acetyleringsgrad

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9403905A SE9403905D0 (sv) 1994-11-14 1994-11-14 New formulations

Publications (1)

Publication Number Publication Date
SE9403905D0 true SE9403905D0 (sv) 1994-11-14

Family

ID=20395954

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9403905A SE9403905D0 (sv) 1994-11-14 1994-11-14 New formulations

Country Status (9)

Country Link
EP (1) EP0792330A1 (sv)
JP (1) JPH10509207A (sv)
AU (1) AU710769B2 (sv)
CA (1) CA2203632A1 (sv)
FI (1) FI972056A0 (sv)
IS (1) IS4469A (sv)
NO (1) NO972172L (sv)
SE (1) SE9403905D0 (sv)
WO (1) WO1996020730A1 (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020018732A1 (en) * 2000-04-21 2002-02-14 Hung William M. Preserving compositions containing chitosan and processes for making water soluble O-acetylated chitosan and chitosan
US6716970B2 (en) 2000-04-21 2004-04-06 Adjuvant Pharmaceuticals, Llc Water soluble, randomly substituted partial N-partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
GB0315632D0 (en) * 2003-07-04 2003-08-13 West Pharm Serv Drug Res Ltd Pharmaceutical formulations
US7125967B2 (en) 2003-10-08 2006-10-24 Adjuvant Pharmaceuticals, Llc Water-soluble chitosan having low endotoxin concentration and methods for making and using the same
US20060287278A1 (en) * 2005-06-21 2006-12-21 Zhenze Hu Method for improving water solubility of chitosan
FR3016882A1 (fr) 2014-01-30 2015-07-31 Sofradim Production Procede de preparation de chitosane a haut degre d’acetylation
EP3034612A1 (en) * 2014-12-16 2016-06-22 Greenaltech, S.L. Chitin and chitosan producing methods
US10646579B2 (en) 2015-11-04 2020-05-12 Tme Therapeutics Inc. Complex comprising RNAi molecule and N-acetylated chitosan
WO2024054707A2 (en) 2022-09-08 2024-03-14 Luna Labs Usa, Llc Layer-by-layer delivery of active agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873092A (en) * 1987-05-21 1989-10-10 Murata Kikai Kabushiki Kaisha Slow-releasing preparation
GB8904370D0 (en) * 1989-02-25 1989-04-12 Cosmas Damian Ltd Liquid delivery compositions
HRP950149A2 (en) * 1994-04-13 1997-06-30 Janssen Pharmaceutica Nv Intranasal antimigrene composition

Also Published As

Publication number Publication date
AU710769B2 (en) 1999-09-30
WO1996020730A1 (en) 1996-07-11
CA2203632A1 (en) 1996-07-11
FI972056A (sv) 1997-05-14
JPH10509207A (ja) 1998-09-08
FI972056A0 (sv) 1997-05-14
EP0792330A1 (en) 1997-09-03
NO972172D0 (no) 1997-05-12
IS4469A (is) 1997-04-22
AU3943395A (en) 1996-07-24
NO972172L (no) 1997-05-12

Similar Documents

Publication Publication Date Title
ES2118834T3 (es) Sistema mejorado de penetracion en la piel para la administracion topica mejorada de farmacos.
NZ295211A (en) Topical aqueous gel containing a water-soluble cellulose derivative, propylene glycol & drug(s) for haemorrhoids
ID28003A (id) Turunan-turunan adamantana
BG101118A (en) Therapeutical compounds
UA26455C2 (uk) Лікарський препарат у формі таблеток із сповільhеhим вивільhеhhям активhого іhгредієhта
NO20002741L (no) Vaksine-blandinger omfattende kitosan, for mukosal administrasjon
MY130477A (en) Pharmaceutical compositions for the treatmen of mucositis, stomatitis and behcet,s syndrome
NO971192L (no) Fremgangsmåter for avlevering av materialer inn i huden, og sammensetninger som blir anvendt
NO20002785D0 (no) Adamantanderivater
CA2274074A1 (en) Novel compounds with analgesic effect
CA2293470A1 (en) Benzimidazole derivatives
IL112572A0 (en) Dexanabinol derivatives and their use as nmda blocking pharmaceutical compositions
EE03004B1 (et) Tselluloosi sisaldava teraviljaekstrakti valmistamise meetod
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
ATE67662T1 (de) Topische antibiotische zusammensetzung zur behandlung der schleimhaeute.
SE9403905D0 (sv) New formulations
EE9900162A (et) Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine
DE69935526D1 (de) Supramolekulare komplexe enthaltende arzneimittel
BR9404225A (pt) Formulação de substância ativa, aplicação, composições, medicamentos e processo para a preparação das formulações
FR2794976B1 (fr) Compositions pharmaceutiques a action cicatrisante ou anti-complementaire comprenant un derive de dextrane
EP0744176A3 (en) Methods for inhibiting bone loss
BR9710629A (pt) Composi-Æo farmac-utica processo para sua prepara-Æo composto para utiliza-Æo como agente terap-utico e utiliza-Æo e utiliza-Æo de um composto
IT1216556B (it) Derivati peptidici del3_aminodiidrotiofen_2_one, loro preparazione e impiego terapeutico.
KR970032876A (ko) 간장질환 치료용 의약 조성물
ITPD920102A0 (it) Composizione farmaceutica utile per trattare malattie gastroenteriche,ferite e ustioni e come agente emostatico